Sana Biotechnology, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC SANA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

240,414

Value ($000)

978

Weight

0.0%

2021 Q4 - 2025 Q4 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	978	0.0%	240,414	12/31/2025
2025 Q3	11/14/2025	499	0.0%	140,647	9/30/2025
2025 Q1	5/19/2025	479	0.0%	284,924	3/31/2025
2024 Q4	2/14/2025	455	0.0%	279,282	12/31/2024
2024 Q3	11/14/2024	1,056	0.0%	253,899	9/30/2024
2024 Q2	8/14/2024	1,349	0.0%	247,076	6/30/2024
2024 Q1	5/15/2024	833	0.0%	83,347	3/31/2024
2023 Q4	2/14/2024	266	0.0%	65,283	12/31/2023
2023 Q3	11/13/2023	223	0.0%	57,595	9/30/2023
2023 Q2	8/11/2023	124	0.0%	37,818	6/30/2023
2023 Q1	5/15/2023	124	0.0%	37,818	3/31/2023
2022 Q4	2/14/2023	208	0.0%	52,618	12/31/2022
2022 Q3	11/14/2022	316	0.0%	52,618	9/30/2022
2022 Q2	8/12/2022	467	0.0%	72,600	6/30/2022
2022 Q1	5/16/2022	203	0.0%	24,600	3/31/2022
2021 Q4	2/14/2022	381	0.0%	24,600	12/31/2021